Noramco

Noramco, founded in 1979, specializes in developing and manufacturing APIs for opioid and non-opioid products. It excels in controlled substance development, offering supply-chain integration, efficient API routes, analytical data, stability studies, regulatory support, formulation-friendly particle sizes, extended technical packages, DEA-compliant security, and scalable production from kilos to multi-tons. Noramco ensures world-class supply security for Schedule I to III controlled substances. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.